Table 2.
Variable | Univariate Survival Analysis | Multivariate Survival Analysis | ||||
---|---|---|---|---|---|---|
HR | 95% CI | p-Value | HR | 95% CI | p-Value | |
Age (Years) | ||||||
<40 | Reference | Reference | ||||
40–59 | 2.558 | 1.540–4.250 | <0.001 | 2.920 | 1.750–4.872 | <0.001 |
≥60 | 7.354 | 4.543–11.905 | <0.001 | 7.610 | 4.674–12.392 | <0.001 |
Sex | ||||||
Female | Reference | Reference | ||||
Male | 1.743 | 1.398–2.172 | <0.001 | 1.011 | 0.797–1.283 | 0.928 |
Race | ||||||
White | Reference | |||||
Black | 0.904 | 0.613–1.334 | 0.611 | - | - | - |
Asian or Pacific Islander | 0.405 | 0.201–0.818 | 0.012 | - | - | - |
American Indian/Alaska Native | 2.160 | 0.537–8.686 | 0.278 | - | - | - |
Tumor Size | ||||||
≤20 | Reference | Reference | ||||
20–40 | 1.651 | 1.253–2.174 | <0.001 | 2.338 | 1.219–4.483 | 0.011 |
≥40 | 3.386 | 2.605–4.401 | <0.001 | 3.330 | 1.826–6.073 | <0.001 |
Stage | ||||||
I | Reference | |||||
II | 1.299 | 0.900–1.873 | 0.162 | - | - | - |
III | 1.275 | 0.794–2.048 | 0.314 | - | - | - |
IV | 4.241 | 3.201–5.620 | <0.001 | - | - | - |
T Stage | ||||||
T1 | Reference | |||||
T2 | 1.299 | 0.942–1.792 | 0.110 | - | - | - |
T3 | 2.508 | 1.889–3.328 | <0.001 | - | - | - |
T4 | 5.136 | 3.753–7.030 | <0.001 | - | - | - |
N Stage | ||||||
N0 | Reference | Reference | ||||
N1a | 1.612 | 1.136–2.287 | 0.007 | 1.327 | 0.981–1.793 | 0.066 |
N1b | 3.007 | 2.373–3.809 | <0.001 | 1.874 | 1.493–2.351 | <0.001 |
M Stage | ||||||
M0 | Reference | Reference | ||||
M1 | 8.317 | 6.364–10.870 | <0.001 | 3.868 | 2.805–5.335 | <0.001 |